PIK3CG and leukemia: Pharmacologic inhibition of PI3K signalling exerted pronounced anti-proliferative effects and induced apoptosis in pre-clinical models using leukemia cell lines or primary leukemia samples, but identified limitations of selectively targeting single nodes within the PI3K/Akt/mTOR cascade.